After recording all the demographic information of patients, including name, age, sex, ..., patients were divided into 2 groups of 64, the first group receiving 100 mg of Cytaglibetin daily, the second group receiving 10 mg of Empagliflozin daily simultaneously with Doses of previous medications and receiving diet and exercise counseling will be divided into three months of treatment, and patients will be studied for 3 months, and the dose of patients' medications will remain constant during these 3 months. It is a drug and this difference will not interfere with the study.) Patients receive periodic visits every month and at each monthly visit, weight is measured by a digital scale with an accuracy of 0.1 kg, height by a bar meter, and standing when the heel The patient's shoulders and shoulders are attached to the wall, and blood pressure is measured by a Richter mercury sphygmomanometer with a suitable arm cuff. Measurements are made by a single person and body mass index will be calculated with the relevant formula. At the end of the third month, venous blood sampling will be performed in patients with fasting conditions and the parameters of FBS, HbA1C, triglyceride, cholesterol, and LDL (measured with BT3000 and Pars test kits) and their weight and blood pressure and mass index Bodies will be evaluated between study groups.